Comparative effectiveness of thromboprophylaxis in acutely ill medical patients across the US acute hospital setting

被引:0
|
作者
Huang, W. [1 ]
Anderson, F. A. [1 ]
Cohen, A. T. [2 ]
机构
[1] Univ Massachusetts, Ctr Outcomes Res, Sch Med, Amherst, MA 01003 USA
[2] Guys Kings & St Thomas Sch Med, Dept Vasc Med, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
O-TH-086
引用
收藏
页码:749 / 749
页数:1
相关论文
共 50 条
  • [31] Contemporary adequacy of thromboprophylaxis in acutely ill medical patients in Switzerland: a bi-centric prospective cohort
    Marando, Marco
    Blondon, Katherine
    Farhoumand, Pauline Darbellay
    Nendaz, Mathieu
    Grauser, Damien
    Sallet, Alain
    Tamburello, Adriana
    Pons, Marco
    Righin, Marc
    Gianella, Pietro
    Blondon, Marc
    SWISS MEDICAL WEEKLY, 2023, 153
  • [32] Updates on the Risk of Dalteparin Thromboprophylaxis Failure in Hospitalized Acutely Ill Medical Patients with Cancer (ARTIC STUDY)
    Louzada, Martha L.
    Al-Ani, Fatimah
    Kovacs, Michael J.
    Siqueira, Lenicio
    Lazo-Langner, Alejandro
    BLOOD, 2015, 126 (23)
  • [33] Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials
    Weitz, Jeffrey I.
    Raskob, Gary E.
    Spyropoulos, Alex C.
    Spiro, Theodore E.
    De Sanctis, Yoriko
    Xu, Jianfeng
    Lu, Wentao
    Suh, Eunyoung
    Argenti, Domenick
    Yang, Haitao
    Albanese, John
    Lipardi, Concetta
    Barnathan, Elliot S.
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (03) : 515 - 524
  • [34] Betrixaban in Acutely Ill Medical Patients
    Cave, Brandon
    Hough, Augustus
    Rosenstein, Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (24):
  • [35] Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients
    McGarry, LJ
    Thompson, D
    Weinstein, MC
    Goldhaber, SZ
    AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (09): : 632 - 642
  • [36] QRS voltage is a predictor of in- hospital mortality of acutely ill medical patients
    Kellett, John
    Opio, Martin Otyek
    CLINICAL CARDIOLOGY, 2018, 41 (08) : 1069 - 1074
  • [37] EnoxaparinA Review of its Use as Thromboprophylaxis in Acutely Ill, Nonsurgical Patients
    M. Asif A. Siddiqui
    Antona J. Wagstaff
    Drugs, 2005, 65 : 1025 - 1036
  • [38] Enoxaparin - A review of its use as thromboprophylaxis in acutely ill, nonsurgical patients
    Siddiqui, MAA
    Wagstaff, AJ
    DRUGS, 2005, 65 (07) : 1025 - 1036
  • [39] Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies
    Spyropoulos, Alex C.
    Lipardi, Concetta
    Cohen, Alexander T.
    Vuckovic, Biljana
    Xu, Jianfeng
    Lu, Wentao
    Spiro, Theodore E.
    Barnathan, Elliot S.
    Raskob, Gary E.
    BLOOD, 2019, 134
  • [40] Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study
    Russell D. Hull
    Sebastian M. Schellong
    Victor F. Tapson
    Manuel Monreal
    Meyer-Michel Samama
    Alexander G. G. Turpie
    Peter Wildgoose
    Roger D. Yusen
    Journal of Thrombosis and Thrombolysis, 2006, 22 : 31 - 38